Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr 7;9(4):772.
doi: 10.3390/microorganisms9040772.

Lassa Virus Treatment Options

Frederick Hansen  1 , Michael A Jarvis  2 , Heinz Feldmann  1 , Kyle Rosenke  1
Affiliations
Review

Lassa Virus Treatment Options

Frederick Hansen et al. Microorganisms. .

Abstract

Lassa fever causes an approximate 5000 to 10,000 deaths annually in West Africa and cases have been imported into Europe and the Americas, challenging public health. Although Lassa virus was first described over 5 decades ago in 1969, no treatments or vaccines have been approved to treat or prevent infection. In this review, we discuss current therapeutics in the development pipeline for the treatment of Lassa fever, focusing on those that have been evaluated in humans or animal models. Several treatments, including the antiviral favipiravir and a human monoclonal antibody cocktail, have shown efficacy in preclinical rodent and non-human primate animal models and have potential for use in clinical settings. Movement of the promising preclinical treatment options for Lassa fever into clinical trials is critical to continue addressing this neglected tropical disease.

Keywords: LASV; Lassa; animal model; antibody; antiviral; therapeutic.

PubMed Disclaimer

Conflict of interest statement

The authors claim no conflict of interest.

References

    1. Frame J.D., Baldwin J.M., Jr., Gocke D.J., Troup J.M. Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings. Am. J. Trop. Med. Hyg. 1970;19:670–676. doi: 10.4269/ajtmh.1970.19.670. - DOI - PubMed
    1. Yun N.E., Walker D.H. Pathogenesis of Lassa fever. Viruses. 2012;4:2031–2048. doi: 10.3390/v4102031. - DOI - PMC - PubMed
    1. Cosset F.L., Marianneau P., Verney G., Gallais F., Tordo N., Pecheur E.I., ter Meulen J., Deubel V., Bartosch B. Characterization of Lassa virus cell entry and neutralization with Lassa virus pseudoparticles. J. Virol. 2009;83:3228–3237. doi: 10.1128/JVI.01711-08. - DOI - PMC - PubMed
    1. Buchmeier M.J., Peters C.J., de la Torre C. Arenaviridae: The viruses and their replication. Fields Virol. 2007;2:1792–1827.
    1. Paolo Colangelo E.V., Leirs H., Tatard C., Denys C., Dobigny G., Duplantier J.-M., Brouat C., Granjon L., Lecompte E. A mitochondrial phylogeographic scenario for the most widespread African rodent, Mastomys natalensis. Biol. J. Linn. Soc. 2013;108:901–916. doi: 10.1111/bij.12013. - DOI

LinkOut - more resources